ArticleBJUI compass2023

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.

Victoria K Woodcock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.